Jean Fernand Armand Lacrampe

This inventor holds 29 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 7 EPO patents, primarily in Kinase Inhibitors. Top assignees: Janssen Pharmaceutica Nv, Astex Therapeutics Limited, Tibotec Pharmaceuticals Ltd.. Active years: 2002-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean Fernand Armand Lacrampe. Retrieved from https://idiyas.com/inventor/jean-fernand-armand-lacrampe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 1)

% Patents Active = 31.0

CIPO Patents = 3

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 5.9

ph-index = 8

Forward Citations = 150(Granted Patents)

Location History:

Issy-Les-Moulineaux Cedex FR (2002)
Issy-les-Moulineaux, Cedex FR (2007)
Le Mesnil-Esnard, FR (2002 - 2017)

Company Filing History:

23 out of 2,103

Janssen Pharmaceutica Nv

patents

3 out of 126

Astex Therapeutics Limited

patents

1 out of 67

Tibotec Pharmaceuticals Ltd.

patents

4. 2 out of 834,659

Other

patents

Years Active: 2002-2017

Loading Chart...

Areas of Expertise:

Pyrazolyl Quinoxaline

MDM2-P53 Interaction

Cell Cycle Kinase

Respiratory Syncytial Virus

Cyclic-Alkylamine Derivatives

Glycogen Synthase Kinase

IL-5 Inhibitors

Heterocyclic Pyrimidines

Piperdine-Amino-Benzimidazole

Toxoflavine Analogues

6-Azauracil Derivatives

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9850228 - Pyrazolyl quinoxaline kinase inhibitors (2017-12-26),

2. 9464071 - Pyrazolyl quinoxaline kinase inhibitors (2016-10-11),

3. 8895601 - Pyrazolyl quinoxaline kinase inhibitors (2014-11-25),

4. 8377961 - Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53 (2013-02-19),

5. 8232298 - Inhibitors of the interaction between MDM2 and P53 (2012-07-31),

6. 8088795 - Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53 (2012-01-03),

7. 7947695 - 5-membered annelated heterocyclic pyrimidines as kinase inhibitors (2011-05-24),

8. 7947694 - Substituted pyrazolo[3,4-D]pyrimidines as cell cycle kinase inhibitors (2011-05-24),

9. 7834016 - Inhibitors of the interaction between MDM2 and p53 (2010-11-16),

10. 7407969 - Respiratory syncytial virus replication inhibitors (2008-08-05),

11. 7390811 - Respiratory syncytial virus replication inhibitors (2008-06-24),

12. 7378433 - N-[4-(heteroarylmethyl)phenyl]-heteroarylamines (2008-05-27),

13. 7361657 - Respiratory syncytial virus replication inhibitors (2008-04-22),

14. 7355051 - Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication (2008-04-08),

15. 7241763 - 3-furanyl analogs of toxoflavine as kinase inhibitors (2007-07-10),

Title: The Innovative Mind of Jean Fernand Armand Lacrampe

Introduction:

Jean Fernand Armand Lacrampe, a talented inventor hailing from Le Mesnil-Esnard, France, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Jean Fernand Armand Lacrampe's latest patents include cutting-edge inventions in the fields of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his versatility and forward-thinking approach.

Career Highlights:

With a career spanning over two decades, Jean Fernand Armand Lacrampe has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has not only revolutionized industries but has also improved the quality of life for many around the world.

Collaborations:

Throughout his career, Jean Fernand Armand Lacrampe has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, Jean Fernand Armand Lacrampe's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, has solidified his reputation as a pioneering inventor in the world of technology. His contributions continue to inspire future generations of inventors to think outside the box and create a better tomorrow.

Profile summary based on public USPTO records.